Cite
HARVARD Citation
Solmone, M. et al. (2014). Slow Response to Entecavir Treatment in Treatment-Naive HBV Patients is Conditioned by Immune Response Rather than by the Presence or Selection of Refractory Variants. Antiviral therapy. 19 (2), pp. 201-209. [Online].